Life Sciences/Biotech

Vestaron Approved By EPA For Pre-Commercial Launch Of Bioinseticide

KALAMAZOO - Vestaron Corporation announced Thursday that the U.S. Environmental Protection Agency has approved the active ingredient in the company?s breakthrough bioinsecticide for commercial sale. The insecticide, a naturally occurring peptide isolated from spiders, is approved for use on a wide variety of crops and has shown no toxicity to fish, birds or mammals, including

By |2014-02-06T00:00:00-05:00February 6th, 2014|Archive, Life Sciences/Biotech|

World-Renowned Cardiovascular Researcher Joins Van Andel Institute

GRAND RAPIDS - Van Andel Research Institute and Spectrum Health announced Wednesday that they have collaborated to bring world-renowned cardiovascular researcher and cardiologist Stefan Jovinge MD, Ph.D. to Grand Rapids. Dr. Jovinge, of Sweden, will lead teams of researchers and clinicians at the Spectrum Health Frederik Meijer Heart & Vascular Institute and Van Andel Research

By |2014-02-05T00:00:00-05:00February 5th, 2014|Archive, Life Sciences/Biotech|

MichBio Annual Biopharmaceutical Manufacturing Survey

ANN ARBOR - MichBio asks its constituents to take a few minutes to complete the bio-industry's most in-depth, global biomanufacturing study - the 11th Annual Biopharmaceutical Manufacturing Survey. Your input is more important than ever, as global and regional trends affecting our industry are bench-marked. By participating, you will receive a FREE summary of the

By |2014-01-29T00:00:00-05:00January 29th, 2014|Archive, Life Sciences/Biotech|

Smart Socks: Biosensors In Clothes May Someday Warn Of Illness

EAST LANSING - A $400,000 National Science Foundation CAREER Award granted to Peter Lillehoj, assistant professor of mechanical engineering at Michigan State University, may soon make it possible for your undershirt or socks warn you about an oncoming infection. Lillehoj will spend the next five years advancing research on innovative wearable biosensors that can be

By |2014-01-22T00:00:00-05:00January 22nd, 2014|Archive, Life Sciences/Biotech|

Report: University Research Corridor Contributes $16.6 Billion To State Economy

LANSING - Michigan's University Research Corridor ranks high among eight university innovation clusters in a new measure that examines R&D spending, research commercialization and talent production, according to a new Economic Impact Report released Wednesday. The URC ? consisting of Michigan State University, the University of Michigan and Wayne State University ? ranked second in

By |2014-01-21T00:00:00-05:00January 21st, 2014|Archive, Life Sciences/Biotech|

ProNAi Closes $12 Million Series C Preferred Financing Round

PLYMOUTH - ProNAi Therapeutics Inc. Monday announced it has closed a Series C preferred financing round of more than $12 million with existing and new investors, the first of several planned financing activities for 2014. The company, in a press release, said the financing reflects ?the impressive clinical progress of the company over the past

By |2014-01-15T00:00:00-05:00January 15th, 2014|Archive, Life Sciences/Biotech|

Accessing Government Funding In A Changing Landscape

ANN ARBOR - Learn how to access government funding for your bioscience company, especially from the Department of Defense during the MichBio sponsored webinar Jan. 17. The speaker, Liz Powell, is a former Legislative Director on Capitol Hill who staffed the Armed Services Committee and became an entrepreneur offering strategic counsel on how to navigate

By |2014-01-07T00:00:00-05:00January 7th, 2014|Archive, Life Sciences/Biotech|

CMS Gives State Green Light On Medicaid Expansion

LANSING - The federal Centers for Medicare and Medicaid Services late Monday gave its approval of Michigan's Medicaid eligibility expansion plan, meaning the state can move ahead with steps to enroll low-income individuals into the health care program. "It's a nice year-end gift for the governor and Legislature," Community Health Director James Haveman said in

By |2014-01-02T00:00:00-05:00January 2nd, 2014|Archive, Life Sciences/Biotech|

Medical Devices, Michigan’s Next Big Thing, But At What Cost?

GRAND RAPIDS - From artificial knees, to robotic surgery, to personalized DNA-based medicine. These technologies are improving patients' quality of life, enabling medical interventions and possibilities not imagined even 10 years ago. What's driving these changes, and is there a downside to all of this? Lean Jan. 8 when the MIT Enterprise Forum hosts Medical

By |2014-01-02T00:00:00-05:00January 2nd, 2014|Archive, Life Sciences/Biotech|